- Summits
- Sponsorship
- Media Opportunities
- News
- About
MedTech Innovator has announced the 20 companies selected for its 2026 Asia Pacific Accelerator Program, following a competitive selection process that drew more than 680 applications from across the region and beyond. The selected startups represent the top 3% of applicants for the eighth edition of the program.
The annual accelerator supports emerging medical technology companies by connecting them with corporate partners, investors, mentors, clinicians, and healthcare stakeholders to help advance commercialization and market access.
According to Fredrik Nyberg, Managing Director, MedTech Innovator Asia Pacific, this year’s applications reflected the growing momentum behind medtech innovation across Asia Pacific.
“The companies selected for the 2026 APAC Accelerator Program stand out not only through the strength of their technologies, but also through their potential to tackle significant healthcare challenges,” Nyberg said. “Through the program, we will connect them with our global network of corporate partners, investors, mentors, and industry leaders to help accelerate their path toward commercialization and patient impact.”
As part of the selection process, 67 startups were invited to pitch during the 2026 Pitch Event RoadTour, which featured four virtual and in-person pitch events. The RoadTour brought together 112 judges and included companies from 14 countries.
The selected companies for the 2026 cohort are:
The accelerator program will run from June to October 2026. Participating companies will begin with the Innovator Summit in San Francisco on June 3-4, followed by the Wilson Sonsini Medical Device Conference on June 5. The program will conclude with the 2026 APAC Grand Finals in Singapore on October 26, where companies will compete for up to USD 275,000 in cash prizes.
The 2026 program is supported by partners including Johnson & Johnson MedTech, B. Braun Medical Industries, Siemens Healthineers, Blue Goat Cyber, FormlyAI, Korea Health Industry Development Institute, Enterprise Singapore, Cambridge Consultants, and The Mullings Group.
Founded to support companies developing transformative healthcare technologies, MedTech Innovator has reviewed more than 14,000 applications globally and supported 838 portfolio companies that have collectively raised over USD 11.4 billion in follow-on funding. Since launching in 2019, its Asia Pacific program has supported startups across 20 countries, with alumni companies collectively raising more than USD 335 million.
The conversation around medtech innovation, commercialization, investment, and cross-border collaboration continues at MedTech World Asia 2026, taking place in Hong Kong from 26–28 August 2026. The event will bring together startups, healthcare leaders, investors, corporates, and innovators from across the global medtech ecosystem. Book your tickets now to be part of the discussions and connections focused on the next phase of healthcare innovation across Asia and beyond.
